Clinical Trial: Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Glioblastoma, IDH-wildtype
Study Type: INTERVENTIONAL
Official Title: An Open-label, Phase 1b Study to Evaluate the Safety and Tolerability of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma
Brief Summary:
The purpose of this study is to establish the recommended phase 2 dose of eflornithine in combination with temozolomide in patients whose glioblastoma is newly diagnosed, and to evaluate safety and tolerability of this combination at that dose.
Read more